{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T00:52:24Z","timestamp":1794099144878,"version":"4.8.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.thromres.2023.10.011","type":"journal-article","created":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T17:24:21Z","timestamp":1697995461000},"page":"15-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Co-administered oral anticoagulants with nonsteroidal anti-inflammatory drugs and the risk of bleeding: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"232","author":[{"given":"Yi","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2023.10.011_bb0005","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1111\/bcp.15371","article-title":"Does coprescribing nonsteroidal anti-inflammatory drugs and oral anticoagulants increase the risk of major bleeding, stroke and systemic embolism?","volume":"88","author":"Penner","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.thromres.2023.10.011_bb0010","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1055\/s-0040-1710592","article-title":"Risk of bleeding with exposure to warfarin and nonsteroidal anti-inflammatory drugs: a systematic review and meta-analysis","volume":"120","author":"Villa Zapata","year":"2020","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.10.011_bb0015","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1055\/s-0042-1750385","article-title":"Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: executive summary of a European and Asia-Pacific expert consensus paper","volume":"122","author":"Gorog","year":"2022","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.10.011_bb0020","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1111\/bcp.14833","article-title":"Drug-drug interactions with warfarin: a systematic review and meta-analysis","volume":"87","author":"Wang","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.thromres.2023.10.011_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114147","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective","volume":"180","author":"Bindu","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.thromres.2023.10.011_bb0030","article-title":"Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study","volume":"354","author":"Arf\u00e8","year":"2016","journal-title":"Bmj"},{"key":"10.1016\/j.thromres.2023.10.011_bb0035","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ki.2015.101","article-title":"Combined use of nonsteroidal anti-inflammatory drugs with diuretics and\/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury","volume":"88","author":"Dreischulte","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.thromres.2023.10.011_bb0040","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/s00535-013-0905-z","article-title":"Aspirin and non-aspirin NSAIDs increase risk of colonic diverticular bleeding: a systematic review and meta-analysis","volume":"49","author":"Yuhara","year":"2014","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.thromres.2023.10.011_bb0045","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/14740338.2021.1965988","article-title":"Gastrointestinal and cardiovascular adverse events associated with NSAIDs","volume":"21","author":"Domper Arnal","year":"2022","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.thromres.2023.10.011_bb0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-230X-9-41","article-title":"Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use","volume":"9","author":"Straube","year":"2009","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.thromres.2023.10.011_bb0055","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1046\/j.1365-2125.2002.01636.x","article-title":"Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data","volume":"54","author":"Lewis","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.thromres.2023.10.011_bb0060","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jacc.2018.04.063","article-title":"Concomitant oral anticoagulant and nonsteroidal anti-inflammatory drug therapy in patients with atrial fibrillation","volume":"72","author":"Kent","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2023.10.011_bb0065","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.thromres.2011.12.005","article-title":"Concomitant use of medication with antiplatelet effects in patients receiving either rivaroxaban or enoxaparin after total hip or knee arthroplasty","volume":"130","author":"Eriksson","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2023.10.011_bb0070","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/ehjcvp\/pvz069","article-title":"Risk of gastrointestinal bleeding associated with oral anticoagulation and non-steroidal anti-inflammatory drugs in patients with atrial fibrillation: a nationwide study","volume":"6","author":"Olsen","year":"2020","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"10.1016\/j.thromres.2023.10.011_bb0075","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1345\/aph.1C157","article-title":"Concomitant coumarin-NSAID therapy and risk for bleeding","volume":"37","author":"Knijff-Dutmer","year":"2003","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.thromres.2023.10.011_bb0080","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1345\/aph.1M284","article-title":"Gastrointestinal safety of nonsteroidal antiinflammatory drugs and selective cyclooxygenase-2 inhibitors in patients on warfarin","volume":"43","author":"Cheetham","year":"2009","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.thromres.2023.10.011_bb0085","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1503\/cmaj.070186","article-title":"Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding","volume":"177","author":"Delaney","year":"2007","journal-title":"Cmaj"},{"key":"10.1016\/j.thromres.2023.10.011_bb0090","first-page":"122","article-title":"Influence of concomitant nsaid or asa on the efficacy and safety of dabigatran versus warfarin for the treatment of acute venous thromboembolism: a pooled analysis from re-cover and re-cover ii","author":"Schulman","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2023.10.011_bb0095","first-page":"640","article-title":"Administrative claims analysis of the relationship between warfarin use and risk of hemorrhage including drug-drug and drug-disease interactions","volume":"12","author":"Zhang","year":"2006","journal-title":"J. Manag. Care Pharm."},{"key":"10.1016\/j.thromres.2023.10.011_bb0100","article-title":"A study of proton pump inhibitors and other risk factors in warfarin-associated gastrointestinal bleeding","volume":"13","author":"Tang","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.thromres.2023.10.011_bb0105","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.10.011_bb0110","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/archinte.165.2.189","article-title":"Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors","volume":"165","author":"Battistella","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.thromres.2023.10.011_bb0115","doi-asserted-by":"crossref","DOI":"10.1007\/s11739-023-03375-9","article-title":"Efficacy and safety of direct oral anticoagulants in older adults with atrial fibrillation: a prospective single-centre cohort study","author":"Catalani","year":"2023","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.thromres.2023.10.011_bb0120","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2710.2005.00676.x","article-title":"Bleeding complications in patients on celecoxib and warfarin","volume":"30","author":"Chung","year":"2005","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.thromres.2023.10.011_bb0125","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/CIRCULATIONAHA.119.041296","article-title":"Patients with atrial fibrillation taking nonsteroidal anti-inflammatory drugs and oral anticoagulants in the ARISTOTLE trial","volume":"141","author":"Dalgaard","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2023.10.011_bb0130","first-page":"26","article-title":"Risk of bleeding in patients with acute venous thromboembolism treated with rivaroxaban or enoxaparin\/VKA and concomitant ASA therapy or NSAIDs: subanalysis from EINSTEIN DVT and PE studies","volume":"11","author":"Davidson","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.10.011_bb0135","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/07853890903186168","article-title":"The effect of drug interactions on bleeding risk associated with warfarin therapy in hospitalized patients","volume":"41","author":"Hauta-Aho","year":"2009","journal-title":"Ann. Med."},{"key":"10.1016\/j.thromres.2023.10.011_bb0140","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1055\/s-0037-1616087","article-title":"Hospitalisation for upper gastrointestinal bleeding associated with use of oral anticoagulants","volume":"86","author":"Johnsen","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.10.011_bb0145","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3349\/ymj.2020.61.9.741","article-title":"Concomitant use of NSAIDs or SSRIs with NOACs requires monitoring for bleeding","volume":"61","author":"Lee","year":"2020","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.thromres.2023.10.011_bb0150","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1177\/1060028013500940","article-title":"Bleeding events following concurrent use of warfarin and oseltamivir by Medicare beneficiaries","volume":"47","author":"Mosholder","year":"2013","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.thromres.2023.10.011_bb0155","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s10147-019-01415-z","article-title":"Use of direct oral anti-coagulants for the treatment of venous thromboembolism in patients with advanced cancer: a prospective observational study","volume":"24","author":"Oyakawa","year":"2019","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.thromres.2023.10.011_bb0160","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/archinternmed.2007.32","article-title":"Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins","volume":"168","author":"Schalekamp","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.thromres.2023.10.011_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021447","article-title":"Antidepressant-warfarin interaction and associated gastrointestinal bleeding risk in a case-control study","volume":"6","author":"Schelleman","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.thromres.2023.10.011_bb0170","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/jama.2015.0809","article-title":"Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction","volume":"313","author":"Schjerning Olsen","year":"2015","journal-title":"Jama"},{"key":"10.1016\/j.thromres.2023.10.011_bb0175","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/1871529X20999201231210044","article-title":"Gastrointestinal bleeding associated with warfarin and rivaroxaban therapy in atrial fibrillation cases with concomitant coagulopathy","volume":"21","author":"Sedaghat","year":"2021","journal-title":"Cardiovasc. Hematol. Disord. Drug Targets"},{"key":"10.1016\/j.thromres.2023.10.011_bb0180","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1001\/archinte.1993.00410140047006","article-title":"Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease","volume":"153","author":"Shorr","year":"1993","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.thromres.2023.10.011_bb0185","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/pds.2219","article-title":"Major bleeding risk associated with warfarin and co-medications in the elderly population","volume":"20","author":"Vitry","year":"2011","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.thromres.2023.10.011_bb0190","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/pds.1737","article-title":"Risk of clinically relevant bleeding in warfarin-treated patients\u2014influence of SSRI treatment","volume":"18","author":"Wallerstedt","year":"2009","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.thromres.2023.10.011_bb0195","doi-asserted-by":"crossref","first-page":"S958","DOI":"10.14309\/00000434-201510001-02310","article-title":"Clinical factors related to gastrointestinal hemorrhage in patients taking non-vitamin k antagonist oral anticoagulants in Japan","volume":"110","author":"Yamamoto","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.thromres.2023.10.011_bb0200","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/bcp.13621","article-title":"Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials","volume":"84","author":"Tse","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.thromres.2023.10.011_bb0205","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2023.10.011_bb0210","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2023.10.011_bb0215","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2023.10.011_bb0220","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/pme.12076","article-title":"Safety of a novel parenteral formulation of diclofenac after major orthopedic or abdominal\/pelvic surgery in a population including anticoagulated, elderly or renally insufficient patients: an open-label, multiday, repeated dose clinical trial","volume":"14","author":"Chelly","year":"2013","journal-title":"Pain Med."},{"key":"10.1016\/j.thromres.2023.10.011_bb0225","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/j.1552-4604.1995.tb04050.x","article-title":"Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis","volume":"35","author":"Schafer","year":"1995","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.thromres.2023.10.011_bb0230","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1161\/CIRCULATIONAHA.106.181424","article-title":"Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association","volume":"115","author":"Antman","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2023.10.011_bb0235","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.thromres.2020.07.054","article-title":"The increased risk of bleeding due to drug-drug interactions in patients administered direct oral anticoagulants","volume":"195","author":"Lee","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2023.10.011_bb0240","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1001\/jama.2018.17242","article-title":"Association of oral anticoagulants and proton pump inhibitor cotherapy with hospitalization for upper gastrointestinal tract bleeding","volume":"320","author":"Ray","year":"2018","journal-title":"Jama"},{"key":"10.1016\/j.thromres.2023.10.011_bb0245","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1053\/j.gastro.2016.08.054","article-title":"Association of proton pump inhibitors with reduced risk of warfarin-related serious upper gastrointestinal bleeding","volume":"151","author":"Ray","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.thromres.2023.10.011_bb0250","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"39","author":"Steffel","year":"2018","journal-title":"Eur. Heart J."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823002888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823002888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:51:07Z","timestamp":1758736267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384823002888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":50,"alternative-id":["S0049384823002888"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.10.011","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-administered oral anticoagulants with nonsteroidal anti-inflammatory drugs and the risk of bleeding: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}